|
(L1) 6501.97929-Abemaciclib, 50 Mg, Coated Tablet, Route Of Administration: Oral, Units. Size: Unit, (L2) 6501.96739-Baricitinib, 2Mg, Tablet, Tablet, (L3) 6502.19669-Carbamazepine, 400Mg, Extended Release Tablet, Blister, Ordinance 344/98: C1, (L4) 6501.31214-Ibrutinib, 140 Mg, (L5) 6501.22591-Icatibant, 30 Mg, Injectable Solution, Prefilled Syringe, 3 Ml, Route Of Administration: Subcutaneous, 02/23/2026 - 15:00:02, (L6) 6501.80156-Insulin Aspart + Nicotinamide, 100 U/Ml, Carpule, Applicator Pen, (L7) 6501.7402-Insulin Lispro, 100 Ui/Ml, (L8) 6501.22919-Nitisinone, 2 Mg, Capsule, (L9) 6501.92260-Semaglutide, 14 Mg, (L10) 6501.48897-Sitagliptin + Metformin, 100Mg + 1000Mg, (L11) 6501.41470-Sitagliptin + Metformin, 50 + 1000 Mg, (L12) 6501.48912-Thyrotropin Alpha, 1.1Mg/Ml, Lyophilized Powder For Solution Injectable, Vial-Ampule, Alfathyrotropin, Route Of Administration: Intramuscular, (L13) 6501.48933-Valsartan + Hydrochlorothiazide, 320Mg + 12.5Mg, (L14) 6501.43726-Valsartan + Hydrochlorothiazide, 320 Mg + 25 Mg, (L15) 6502.52089-Zuclopenthixol, 25 Mg
|